Skip to content
Subscriber Only

Swiss Firm Could Make Russian Vaccine as Early as Third Quarter

  • Adienne Pharma head Di Naro speaks in Bloomberg interview
  • No decision on where vaccine will be distributed, Di Naro says
Bloomberg business news
WATCH: Antonio Francesco Di Naro, Adienne Pharma CEO and Founder, says deciding to produce the Sputnik V Covid-19 vaccine in Italy ''is not a propaganda tool." (Source: Bloomberg)

The first European company to reach a deal to produce Russia’s Covid-19 vaccine said it could start manufacturing as early as the third quarter, and rejected charges it was part of a propaganda effort as “absurd.”

Antonio Francesco Di Naro, founder and president of Adienne Pharma & Biotech SA, said Wednesday that his company had been selected to make the Sputnik V vaccine following an approach from Russia.